Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
Long-term nucleos(t)ide analogues (NUCs) treatment is usually required for patients with chronic hepatitis B (CHB). However, whether discontinuation of NUCs is possible in selected patients remains debated. The aim of this study was to assess the durability of NUCs and predictors of sustained respon...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Wolters Kluwer Health
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616713/ |